STRO — SUTRO BIOPHARMA INC

Ownership history in XTX Topco Ltd  ·  12 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in SUTRO BIOPHARMA INC (STRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.17% (2022 Q4)
Avg. % of fund
0.05%
First filed
2022 Q2
Last filed
2025 Q3
Quarters held
12
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 19,131 -6,035 -24.0% 0.00% $17K $8.70
2025 Q1 ADDED 25,166 +3,357 +15.4% 0.00% $16K $6.50
2024 Q4 REDUCED 21,809 -82,391 -79.1% 0.00% $40K $18.40
2024 Q3 ADDED 104,200 +71,844 +222.0% 0.03% $361K $34.60
8 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    STRO price (monthly, adj. close)

Other funds also holding STRO

As of 2025 Q4 — sorted by position size

Velan Capital Investment Management LP 3Y 2.09% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 0.53% Affinity Asset Advisors, LLC 3Y 0.49% Kynam Capital Management, LP 3Y 0.35% Opaleye Management Inc. 3Y 7Y 0.29% Samsara BioCapital, LLC 3Y 7Y 0.24% Eversept Partners, LP 3Y 7Y 0.11% Vestal Point Capital, LP 0.1% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.09% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.08%
← Back to XTX Topco Ltd Holdings